CDK9 and neoplasm: In metastatic TNBC models, complex 8 reduced the coprecipitation between CCNT1 and CDK9 and decreasedmRNA levels of c-MYC and Mcl-1 in tumor tissues, which suggested thatcomplex 8 disrupted the CDK9–CCNT1 PPI in vivo.